Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,843 | -27,274 | -12,546 | -6,895 | -2,812 |
| Depreciation Amortization | 2,200 | 9,188 | 6,936 | 4,719 | 2,387 |
| Income taxes - deferred | -107 | 5,268 | -2,996 | -1,577 | -640 |
| Accounts receivable | 546 | -1,522 | -847 | -2,097 | 1,547 |
| Accounts payable and accrued liabilities | N/A | 1,608 | 349 | 487 | 200 |
| Other Working Capital | -7,313 | -12,276 | -11,703 | -11,269 | -7,802 |
| Other Operating Activity | 1,715 | 7,785 | 6,084 | 5,406 | 94 |
| Operating Cash Flow | $-10,802 | $-17,223 | $-14,723 | $-11,226 | $-7,026 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -977 | -3,370 | -2,798 | -1,937 | -782 |
| Sale Of Investment | N/A | 9,600 | 7,600 | 7,600 | 4,000 |
| Investing Cash Flow | $-977 | $6,230 | $4,802 | $5,663 | $3,218 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,664 | N/A | 0 | 0 | N/A |
| Common Stock Issued | 347 | 1,246 | 763 | 741 | 230 |
| Other Financing Activity | -11,211 | -1,621 | -1,436 | -1,401 | -853 |
| Financing Cash Flow | $18,800 | $-375 | $-673 | $-660 | $-623 |
| Exchange Rate Effect | 411 | -787 | -485 | -218 | -72 |
| Beginning Cash Position | 18,998 | 31,153 | 31,153 | 31,153 | 31,153 |
| End Cash Position | 26,430 | 18,998 | 20,074 | 24,712 | 26,650 |
| Net Cash Flow | $7,432 | $-12,155 | $-11,079 | $-6,441 | $-4,503 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,802 | -17,223 | -14,723 | -11,226 | -7,026 |
| Capital Expenditure | -977 | -3,370 | -2,798 | -1,937 | -782 |
| Free Cash Flow | -11,779 | -20,593 | -17,521 | -13,163 | -7,808 |